HER-2 status of circulating tumor cells in a metastatic breast cancer cohort: A comparative study on characterization techniques

BACKGROUND: Personalized targeted treatment in metastatic breast cancer relies on accurate assessment of molecular aberrations, e.g. overexpression of Human Epidermal growth factor Receptor 2 (HER-2). Molecular interrogation of circulating tumor cells (CTCs) can provide an attractive alternative for...

Descripción completa

Detalles Bibliográficos
Autores principales: Brouwer, Anja, De Laere, Bram, van Dam, Pieter-Jan, Peeters, Dieter, Van Haver, Jasper, Sluydts, Ellen, El Moussaoui, Ali, Mendelaar, Pauline, Kraan, Jaco, Peeters, Marc, Van Laere, Steven, Dirix, Luc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6726188/
https://www.ncbi.nlm.nih.gov/pubmed/31483799
http://dx.doi.org/10.1371/journal.pone.0220906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6726188/
https://www.ncbi.nlm.nih.gov/pubmed/31483799
http://dx.doi.org/10.1371/journal.pone.0220906

Ejemplares similares